Viewing Study NCT00103051


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2026-01-01 @ 10:46 AM
Study NCT ID: NCT00103051
Status: COMPLETED
Last Update Posted: 2012-07-16
First Post: 2005-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module